Literature DB >> 2664504

Effect of hypertonic solutes upon the polysaccharide capsule in Cryptococcus neoformans.

E S Jacobson, M J Tingler, P L Quynn.   

Abstract

The polysaccharide capsule is a characteristic virulence factor in the yeast-pathogen, Cryptococcus neoformans. Growth in hypertonic growth media results in yeast cells with visibly smaller capsules. We investigated this suppression quantitatively, using a chemical assay for cell-bound and dissolved capsular polysaccharide. Molar NaCl suppressed production of cell-bound polysaccharide by a factor of 2.5- to 5-fold. The possibility of salt-induced physico-chemical contraction of capsular gel was tested by dialysis of fixed cells from hypotonic medium against medium containing 1 M NaCl and against the original medium again, while capsular thickness, packed cell volume and cell-bound polysaccharide were followed. We detected a physical contraction of gel following dialysis against medium containing 1 M NaCl. Mutants which gave mucoid colonies on hypertonic agar were isolated. One of these gave twice as much polysaccharide as the wild type when cultivated in medium containing 1 M NaCl. The hypercapsular trait was passed through serial outcrosses to the wild type and segregated as a chromosomal gene. This mutant may represent a gene which regulates production of capsular polysaccharide.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2664504     DOI: 10.1111/j.1439-0507.1989.tb02163.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  13 in total

Review 1.  A yeast under cover: the capsule of Cryptococcus neoformans.

Authors:  Indrani Bose; Amy J Reese; Jeramia J Ory; Guilhem Janbon; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2003-08

2.  Expression of capsule-associated genes of Cryptococcus neoformans.

Authors:  Ken Okabayashi; Rui Kano; Shinichi Watanabe; Atsuhiko Hasegawa
Journal:  Mycopathologia       Date:  2005-08       Impact factor: 2.574

Review 3.  Virulence factors of medically important fungi.

Authors:  L H Hogan; B S Klein; S M Levitz
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

4.  The pathogenic fungus Cryptococcus neoformans expresses two functional GDP-mannose transporters with distinct expression patterns and roles in capsule synthesis.

Authors:  Tricia R Cottrell; Cara L Griffith; Hong Liu; Ashley A Nenninger; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2007-03-09

5.  Cryptococcus neoformans-astrocyte interactions: effect on fungal blood brain barrier disruption, brain invasion, and meningitis progression.

Authors:  Yeon Hwa Woo; Luis R Martinez
Journal:  Crit Rev Microbiol       Date:  2021-01-21       Impact factor: 7.624

6.  Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations.

Authors:  Leonardo Nimrichter; Susana Frases; Leonardo P Cinelli; Nathan B Viana; Antonio Nakouzi; Luiz R Travassos; Arturo Casadevall; Marcio L Rodrigues
Journal:  Eukaryot Cell       Date:  2007-06-15

7.  An unusual organelle in Cryptococcus neoformans links luminal pH and capsule biosynthesis.

Authors:  Aki Yoneda; Tamara L Doering
Journal:  Fungal Genet Biol       Date:  2009-05-18       Impact factor: 3.495

8.  Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2).

Authors:  Oscar Zaragoza; Bettina C Fries; Arturo Casadevall
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

9.  A Rare Case of Primary Supraclavicular Lymphadenitis due to Cryptococcus Neoformans in an HIV Infected Patient.

Authors:  Anuradha Sood; Lata R Chandel; Smriti Chauhan; Kamlesh Thakur; S C Jaryal
Journal:  J Clin Diagn Res       Date:  2014-02-03

10.  Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival.

Authors:  Oscar Zaragoza; Cara J Chrisman; Maria Victoria Castelli; Susana Frases; Manuel Cuenca-Estrella; Juan Luis Rodríguez-Tudela; Arturo Casadevall
Journal:  Cell Microbiol       Date:  2008-06-28       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.